ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 917

$465K Total Retail Price of All Prescriptions

Rank: 140 out of 917

634 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
OMEPRAZOLE 440 369 1 4
LISINOPRIL 439 422 2 1
LEVOTHYROXINE SODIUM 386 352 3 3
HYDROCODONE-ACETAMINOPHEN 367 245 S3 4 6
LOVASTATIN 323 304 5 19
SIMVASTATIN 322 307 6 2
ATENOLOL 273 255 7 12
ATORVASTATIN CALCIUM 256 248 8 14
HYDROCHLOROTHIAZIDE 221 213 9 9
ZOLPIDEM TARTRATE 190 171 10 21
TRAMADOL HCL 183 145 11 28
PRAVASTATIN SODIUM 166 151 12 20
CITALOPRAM HBR 157 153 13 15
METOPROLOL SUCCINATE 143 124 14 18
FUROSEMIDE 138 123 15 7
METOPROLOL TARTRATE 130 123 16 11
AMLODIPINE BESYLATE 130 126 16 5
LOSARTAN POTASSIUM 124 117 18 13
METFORMIN HCL 121 116 19 8
TRIAMTERENE-HYDROCHLOROTHIAZID 120 115 20 147
FLUOXETINE HCL 117 99 21 38
WARFARIN SODIUM 104 103 22 10
TRIAMTERENE-HCTZ 100 87 23 36
CLOPIDOGREL 99 95 24 50
CRESTOR 96 89 25 30
PROAIR HFA 96 73 25 35
ALLOPURINOL 93 85 27 31
TAMSULOSIN HCL 87 78 28 25
DIGOXIN 87 86 28 41
TRAZODONE HCL 87 66 28 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 75 31 42
PANTOPRAZOLE SODIUM 81 77 32 44
POTASSIUM CHLORIDE 80 75 33 16
OXYCODONE-ACETAMINOPHEN 79 64 S2 34 46
GLIMEPIRIDE 78 78 35 54
FLUTICASONE PROPIONATE 77 77 36 26
GABAPENTIN 71 50 37 17
PLAVIX 71 70 37 84
VENLAFAXINE HCL ER 68 63 39 78
LANTUS 62 50 40 37
AZITHROMYCIN 61 51 41 61
BENAZEPRIL HCL 61 61 41 80
ISOSORBIDE MONONITRATE ER 59 59 43 70
CIPROFLOXACIN HCL 54 49 44 72
AMITRIPTYLINE HCL 52 40 R 45 67
SERTRALINE HCL 50 43 46 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.